Drugs / Thiocolchicoside
Thiocolchicoside
also known as
Coltramyl · Coltrax · Miorel · Musco-ril · NSC-147755 · TCC · Thiocolchicine 2-glucoside analog · Tiocolchicosido
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06261320 | Feb 2024 → Dec 2026 expected | inflammatory bowel disease | Polyclinique de l'Europe | Active not recruiting | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT07586072 | Aug 2024 → Aug 2025 | bruxism, myofascial pain syndrome, temporomandibular joint disorder | Recep Tayyip Erdogan University | Completed | No outcome recorded |
| Phase 4 | NCT00272532 | Apr 2005 → ? | myofascial pain syndrome | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00917436 | Dec 2004 → Jul 2005 | — | Sanofi | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04110119 Background | Oct 2018 → Nov 2019 | — | Medipol University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00679146 Comparator | Apr 2008 → Jun 2009 | — | Sanofi | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06791434 Background | Aug 2024 → Aug 2025 | — | Dr. Vishwanath Karad MIT World Peace University | Completed | No outcome recorded |
| Phase 4 | NCT05529290 Comparator | Jul 2019 → Jul 2021 | temporomandibular joint disorder | Yuzuncu Yil University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05261971 Comparator | Dec 2018 → Mar 2020 | — | Yuzuncu Yil University | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Thiocolchicoside | “Composition per tablet: Etoricoxib 60 mg + Thiocolchicoside 4 mg” NCT06791434 ↗ |
| Known as | Coltramyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | Coltrax | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | Miorel | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | Musco-ril | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | NSC-147755 | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | TCC | “the oral fixed - combination of a muscle relaxant, thiocolchicoside (TCC) to a non steroidal anti-inflammatory drug, ketoprofen, over oral TCC” NCT00679146 ↗ |
| Known as | Thiocolchicine 2-glucoside analog | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Known as | Tiocolchicosido | ChEMBL registry synonym — accepted as the source's own label CHEMBL213907 ↗ |
| Modality | Small molecule | — CHEMBL213907 ↗ |
| Route | Topical | “thiocolchicoside ointment administered to trigger point regions” NCT00272532 ↗ |